Filing Details
- Accession Number:
- 0001127602-20-019788
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-16 17:53:00
- Reporting Period:
- 2020-06-12
- Accepted Time:
- 2020-06-16 17:53:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 313143 | Haemonetics Corp | HAE | Surgical & Medical Instruments & Apparatus (3841) | 042882273 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1713517 | Jacqueline Scanlan | 125 Summer Street Boston MA 02110 | Svp, Global Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-06-12 | 11,286 | $0.00 | 17,000 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2020-06-12 | 111 | $89.29 | 16,889 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-06-15 | 4,417 | $87.71 | 12,472 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-06-15 | 2,889 | $41.64 | 15,361 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-06-15 | 4,005 | $90.00 | 11,356 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-06-16 | 6,869 | $91.53 | 4,487 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2020-06-15 | 2,889 | $0.00 | 2,889 | $41.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,890 | 2020-06-06 | 2024-06-06 | No | 4 | M | Direct |
Footnotes
- Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020.
- This number includes unvested restricted stock units ("RSUs") previously reported.
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- Transaction pursuant to an existing 10b5-1 trading plan.
- Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
Billionaire Hedge Funds
